Helixmith Co. Ltd Total Liabilities
Helixmith Co. Ltd total liabilities. Based on the latest financial reports, Helixmith Co. Ltd (084990) has total liabilities worth ₩1.57 Billion KRW (≈ $1.06 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check financial resilience of Helixmith Co. Ltd to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Helixmith Co. Ltd (2010–2025)
Total liabilities of Helixmith Co. Ltd from 2010 to 2025. This chart illustrates how Helixmith Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore Helixmith Co. Ltd (084990) investment intensity to see how much of total assets are deployed in long-term investments.
Helixmith Co. Ltd Competitors by Total Liabilities
The table below lists competitors of Helixmith Co. Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Artemis Hali As
IS:ARTMS
|
Turkey | TL559.16 Million |
|
Samebest Co Ltd
TWO:8489
|
Taiwan | NT$1.08 Billion |
|
SINCLAIRS HOTELS ORD (BSE)
NSE:SINCLAIR
|
India | Rs-1.21 Billion |
|
Fiyta Holdings Ltd
SHE:200026
|
China | HK$351.90 Million |
|
RFTech Co. Ltd
KQ:061040
|
Korea | ₩203.65 Billion |
|
Train Alliance Sweden AB Series B
ST:TRAIN-B
|
Sweden | Skr785.98 Million |
|
Visang Educati
KO:100220
|
Korea | ₩183.60 Billion |
Liability Composition Analysis (2010–2025)
This chart breaks down Helixmith Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Helixmith Co. Ltd balance sheet assets.
Liquidity & Leverage Metrics
Helixmith Co. Ltd Total Liabilities Ratios Explained
Helixmith Co. Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 56.69 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.01 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.01 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Helixmith Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Helixmith Co. Ltd (2010–2025)
The table below shows the annual total liabilities of Helixmith Co. Ltd from 2010 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | ₩1.67 Billion ≈ $1.13 Million |
-75.58% |
| 2024-12-31 | ₩6.85 Billion ≈ $4.64 Million |
-90.68% |
| 2023-12-31 | ₩73.56 Billion ≈ $49.85 Million |
+97.41% |
| 2022-12-31 | ₩37.26 Billion ≈ $25.25 Million |
-34.80% |
| 2021-12-31 | ₩57.15 Billion ≈ $38.73 Million |
-71.68% |
| 2020-12-31 | ₩201.84 Billion ≈ $136.78 Million |
+14.76% |
| 2019-12-31 | ₩175.87 Billion ≈ $119.19 Million |
+16.96% |
| 2018-12-31 | ₩150.37 Billion ≈ $101.90 Million |
+907.27% |
| 2017-12-31 | ₩14.93 Billion ≈ $10.12 Million |
+110.01% |
| 2016-12-31 | ₩7.11 Billion ≈ $4.82 Million |
+108.25% |
| 2015-12-31 | ₩3.41 Billion ≈ $2.31 Million |
+28.48% |
| 2013-12-31 | ₩2.66 Billion ≈ $1.80 Million |
-24.95% |
| 2012-12-31 | ₩3.54 Billion ≈ $2.40 Million |
-65.81% |
| 2011-12-31 | ₩10.35 Billion ≈ $7.02 Million |
-38.67% |
| 2010-12-31 | ₩16.88 Billion ≈ $11.44 Million |
-- |
About Helixmith Co. Ltd
Helixmith Co., Ltd, a biotechnology company, discovers and develops biopharmaceuticals for human diseases. The company has a pipeline of novel biologics and herbal therapeutics in the areas of cardiovascular disease, cancer, and immune disorder, with clinical studies ongoing in the United States, Korea, and China. Its flagship product is VM202, a DNA-based drug for cardiovascular and neurological… Read more